Medicare and GLP-1 weight loss drugs have a complicated history. For years, Medicare would only cover GLP-1s if you had type 2 diabetes — not for weight loss alone. That is starting to change. The Medicare GLP-1 bridge program is a step toward broader coverage, but it comes with limits.
Here is what you need to know.
Quick Answer
Medicare's bridge program gives temporary coverage for GLP-1 medications prescribed for obesity. CMS extended it in 2026. This means some Medicare beneficiaries can now get Wegovy, Zepbound, or similar drugs covered — but only for a limited time and only if your plan participates. When the bridge ends, you may need another path to afford your medication.
The Background: Why This Matters
For a long time, Medicare had a rule: it would not cover weight loss drugs. This dated back to a 2003 law that excluded "weight loss agents" from Medicare Part D coverage.
GLP-1s changed the conversation. Drugs like Wegovy and Zepbound are not just for weight loss — they reduce the risk of heart attack and stroke in people with cardiovascular disease. That medical benefit made it harder for Medicare to justify keeping them excluded.
CMS created the bridge program as a temporary solution. It lets Medicare plans cover GLP-1s for obesity treatment while broader policy decisions are worked out.
What the Bridge Program Covers
The bridge program allows Medicare plans to cover GLP-1 medications when they are prescribed for obesity. This includes:
- Wegovy (semaglutide) — FDA-approved for weight management
- Zepbound (tirzepatide) — FDA-approved for weight management
- Saxenda (liraglutide) — FDA-approved for weight management
Important: If you have type 2 diabetes and are prescribed a GLP-1 for blood sugar control, that is already covered under standard Medicare Part D. The bridge program is specifically for people who need GLP-1s for obesity without a diabetes diagnosis.
Who Qualifies
Eligibility depends on your specific plan, but generally you may qualify if:
- You are enrolled in Medicare (Part D or Medicare Advantage)
- Your plan participates in the bridge program
- You have a BMI of 30 or higher (or 27+ with a weight-related condition)
- Your doctor prescribes a GLP-1 for obesity treatment
- Your plan's prior authorization requirements are met
Not all Medicare plans participate. You need to check directly with your plan.
How to Check If Your Plan Covers It
Step 1: Call Your Plan
Call the member services number on the back of your Medicare card. Ask:
- "Does my plan cover GLP-1 medications for weight loss?"
- "Is the bridge program available on my plan?"
- "What are the prior authorization requirements?"
- "What will my copay be?"
Write down the date, the representative's name, and what they told you.
Step 2: Check Your Formulary
Your plan's formulary (drug list) is available online. Search for Wegovy, Zepbound, or Saxenda. If they are listed with obesity as a covered indication, you may be in luck.
Step 3: Talk to Your Doctor
Your doctor's office handles prior authorizations regularly. They can tell you:
- Whether they have gotten GLP-1s approved for other Medicare patients
- What documentation you need (BMI, weight history, comorbidities)
- How long the approval process typically takes
What the Bridge Program Does NOT Do
This is where it gets real:
- It is not permanent. The bridge is temporary. CMS has extended it, but there is no guarantee it becomes standard coverage.
- Not all plans participate. Some Medicare Advantage plans include it; others do not. Original Medicare with a standalone Part D plan may have different rules.
- It may have step therapy requirements. Your plan might require you to try cheaper medications first.
- Copays still apply. Even with coverage, you may have a copay or be in the coverage gap (donut hole).
What Happens When the Bridge Ends
If the bridge program ends and you are on a GLP-1, you could lose coverage. Plan ahead:
Option 1: Manufacturer Patient Assistance Programs
Novo Nordisk and Eli Lilly both have programs for low-income patients. These can provide medications at reduced cost or free. Income limits apply — usually around 400-500% of the federal poverty level.
Option 2: Switch to a Medicare Advantage Plan With Weight Loss Coverage
During open enrollment, you can switch to a Medicare Advantage plan that includes weight loss medications. Compare plans carefully — coverage varies a lot.
Option 3: Compounded GLP-1s
Licensed compounding pharmacies can make semaglutide for $200-$500/month. This is cheaper than brand-name but more expensive than insurance coverage. Read our compounded semaglutide safety guide before going this route.
Option 4: Talk to Your Doctor About Alternatives
Your doctor may suggest other weight management options that Medicare already covers, such as:
- Generic liraglutide (Saxenda's active ingredient may be available generically in the future)
- Other FDA-approved weight loss medications with lower costs
- Behavioral counseling (Medicare covers obesity counseling in primary care settings)
How This Connects to Other Coverage Paths
If you are on Medicare and looking for GLP-1 access, you have a few paths:
- Bridge program — Temporary, plan-specific, covers obesity indication
- Part D for diabetes — Permanent coverage if you have type 2 diabetes
- Amazon One Medical — Not insurance, but their primary care membership ($99/year with Prime) can prescribe GLP-1s. You still pay for the medication. See our Amazon One Medical GLP-1 guide.
- Manufacturer savings — Limited for Medicare patients but worth checking
The Bigger Picture
The bridge program is a sign that Medicare coverage for GLP-1 weight loss drugs is moving in the right direction. But it is not a done deal yet. Policy changes take time, and there is active debate about whether Medicare should permanently cover anti-obesity medications.
If you benefit from the bridge program, keep documenting your progress. Weight loss, improved blood pressure, better mobility — these are the outcomes that help make the case for permanent coverage.
Bottom Line
The Medicare GLP-1 bridge program is real, it has been extended, and it may help you afford Wegovy or Zepbound if your plan participates. But it is temporary. Check with your plan, work with your doctor, and have a backup plan in case coverage ends.
For a full breakdown of insurance options for GLP-1s, see our insurance coverage guide.
This article is for informational purposes only and does not constitute medical or insurance advice. Medicare coverage varies by plan and changes frequently. Always verify coverage directly with your Medicare plan provider.
